LOST: Leukocytes - ObeSity - Spontaneous Labour

Sponsor
Centre Hospitalier Universitaire Dijon (Other)
Overall Status
Recruiting
CT.gov ID
NCT02085772
Collaborator
(none)
60
1
1
107.9
0.6

Study Details

Study Description

Brief Summary

This is a single-centre observational, prospective study carried out at the maternity unit of Dijon CHU. It will include pregnant women with a pre-conception BMI ≥ 30 kg/m² and will evaluate in these patients, the activation and migration capacities of circulating leukocytes and their association with the onset of spontaneous labour.

Patients who meet the inclusion criteria will be informed about the study during their consultation at the 7th or 8th month, and their gynecologist will invite them to take part. If the answer is positive, the patients will be seen again at a specific consultation for the study between the 37th and 38the Weeks of amenorrhea at the maternity unit of Dijon CHU. During this consultation, the gynecologist will conduct a medical examination, while the Plurithematic clinical investigation center nurse will take a blood sample (3 x 6ml tubes and 1 x 7ml tube).

If labour has not started by 41 Weeks of amenorrhea, the patients will be seen at another consultation (consultation programmed in the usual follow-up of pregnancy) and a second blood sample (1 x 6ml tube and 1 x 7ml) will be taken.

The patients will be followed until childbirth and will be split into two groups according to whether or not they gave birth after the onset of spontaneous labour.

Condition or Disease Intervention/Treatment Phase
  • Other: Blood samples at 37-38 Weeks of amenorrhea
  • Other: Blood samples at 41 Weeks of amenorrhea if prolonged pregnancy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Primary Purpose:
Other
Official Title:
Is Impaired Activation and Migration of Circulating Leukocytes Associated With Overdue Birth in Obese Women?
Actual Study Start Date :
Feb 5, 2014
Anticipated Primary Completion Date :
Feb 1, 2023
Anticipated Study Completion Date :
Feb 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Patients with pre-conceptional obesity

Other: Blood samples at 37-38 Weeks of amenorrhea

Other: Blood samples at 41 Weeks of amenorrhea if prolonged pregnancy

Outcome Measures

Primary Outcome Measures

  1. To determine the initiation of spontaneous labour [Women will be followed until the release of motherhood after giving birth]

Secondary Outcome Measures

  1. Occurrence of a vaginal delivery [Women will be followed until the release of motherhood after giving birth]

  2. Occurrence of prolonged pregnancy [Women will be followed until the release of motherhood after giving birth]

  3. Occurrence of a term exceeding [Women will be followed until the release of motherhood after giving birth]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient has given its written consent

  • Please affiliated to a social security scheme

  • Body Mass Index Preconception ≥ 30 kg / m²

  • Age> 18 years

  • Unique Pregnancy

  • Having a plot of Normal Fetal heart rate

Exclusion Criteria:
  • Pathology changing the mode of delivery or induction of labor (pre-eclampsia, chronic hypertension or gestational, diabetes under unbalanced diet, ...)

  • Scheduled Caesarean

  • Infectious Disease suspected or proven, including HIV infection, hepatitis C, hepatitis B

  • Pathology inflammatory or autoimmune

  • Anti-inflammatory or immunosuppressive therapy

  • Patient under guardianship

  • Patient in safeguarding justice

• SECONDARY EXCLUSION CRITERIA:

  • Caesarean section before labor

  • Delivery before 37 Weeks of amenorrhea

  • Anti-inflammatory or immunosuppressive therapy during study participation

  • Fetal Heart Rate abnormal during study participation

  • Premature rupture of fetal membranes without formal labor spontaneously within 48 hours

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU de DIJON Dijon France 21079

Sponsors and Collaborators

  • Centre Hospitalier Universitaire Dijon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire Dijon
ClinicalTrials.gov Identifier:
NCT02085772
Other Study ID Numbers:
  • WENDREMAIRE APJ 2013
First Posted:
Mar 13, 2014
Last Update Posted:
Sep 14, 2021
Last Verified:
Sep 1, 2021
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 14, 2021